PharmaEssentia Corporation (LUX:261280523)

PharmaEssentia Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	21,051	19,666	10,304	3,454	3,200
Short-Term Investments	-	-	-	-	12
Cash & Short-Term Investments	21,051	19,666	10,304	3,454	3,212
Cash Growth	7.04%	90.86%	198.34%	7.51%	130.17%
Accounts Receivable	2,624	1,312	798.87	466.04	450.6
Other Receivables	208.01	236.08	41.22	27.17	2.74
Receivables	2,832	1,548	840.09	493.22	453.34
Inventory	1,287	1,459	1,102	861.38	394.85
Prepaid Expenses	163.58	151.92	55.64	49.02	43.95
Other Current Assets	83.63	71.18	1,074	69.41	42.91
Total Current Assets	25,417	22,896	13,375	4,927	4,147
Property, Plant & Equipment	3,361	2,733	1,018	764.93	891.66
Long-Term Investments	542.44	163.92	43.24	39.22	95.23
Other Intangible Assets	272.72	267.91	236.88	246.25	220.65
Long-Term Deferred Tax Assets	1,120	958.46	483.42	-	-
Other Long-Term Assets	347.95	249.72	176.38	221.13	176.22
Total Assets	31,062	27,269	15,333	6,198	5,531
Accounts Payable	126.47	128.88	230.96	176.38	177.07
Accrued Expenses	1,106	970.52	667.45	405.5	275.37
Short-Term Debt	-	21	993.88	20	50
Current Portion of Long-Term Debt	11.9	12.36	12.14	12.05	6.5
Current Portion of Leases	180.56	211.85	77.76	78.59	90.27
Current Income Taxes Payable	-	0.99	-	-	-
Current Unearned Revenue	0.23	-	-	-	-
Other Current Liabilities	1,132	806.49	568.16	719.44	487.5
Total Current Liabilities	2,557	2,152	2,550	1,412	1,087
Long-Term Debt	50.81	62.71	74.98	87.09	99.2
Long-Term Leases	722.16	892.29	410.05	338.51	400.76
Long-Term Deferred Tax Liabilities	81.32	105.96	8.22	-	-
Other Long-Term Liabilities	170.21	97.91	143.64	106.3	20.79
Total Liabilities	3,593	3,321	3,191	1,948	1,611
Common Stock	3,418	3,403	3,025	2,769	2,634
Additional Paid-In Capital	23,547	24,092	13,421	4,697	3,727
Retained Earnings	2,974	-631.19	-4,186	-2,811	-2,144
Treasury Stock	-2,805	-2,805	-87.5	-344.74	-257.24
Comprehensive Income & Other	335.89	-110.37	-31.54	-60.15	-40.44
Shareholders' Equity	27,469	23,948	12,141	4,250	3,920
Total Liabilities & Equity	31,062	27,269	15,333	6,198	5,531
Total Debt	965.43	1,200	1,569	536.24	646.73
Net Cash (Debt)	20,086	18,466	8,735	2,917	2,566
Net Cash Growth	8.77%	111.40%	199.41%	13.71%	164.17%
Net Cash Per Share	60.13	57.26	30.73	11.21	10.59
Filing Date Shares Outstanding	332.89	331.36	301.55	273.06	260.48
Total Common Shares Outstanding	332.89	331.36	301.55	273.06	260.48
Working Capital	22,860	20,744	10,825	3,515	3,061
Book Value Per Share	82.52	72.27	40.26	15.57	15.05
Tangible Book Value	27,196	23,680	11,904	4,004	3,699
Tangible Book Value Per Share	81.70	71.46	39.48	14.66	14.20
Land	58.24	58.24	58.24	58.24	58.24
Buildings	70.86	70.63	70.61	70.52	70.54
Machinery	811.38	723.26	534.93	486.58	442.21
Construction In Progress	2,011	1,188	234.56	36.49	42.56
Leasehold Improvements	429.87	426.29	371.12	341.61	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.